Navigation Links
Yongye Biotechnology International Announces Second Quarter Results
Date:8/18/2008

30, 2008, up 232.0% from $8.1 million in the six months ended June 30, 2007. Gross profit was $14.6 million with a gross margin of 54.0%, compared to $3.8 million with a gross margin of 46.5% in the six months ended June 30, 2007. Operating income was $9.8 million with an operating margin of 36.2%, compared to $3.6 million with an operating margin of 43.7% in the six months ended June 30, 2007. Net income was $7.7 million, or $0.54 per diluted share, compared to $3.4 million, or $0.29 per diluted share, in the six months ended June 30, 2007.

Financial Condition

On June 30, 2008, cash totaled $1.4 million, compared to $376,002 as of December 31, 2007. Accounts receivable were $20.6 million as of June 30, 2008, compared to $1.6 million as of December 31, 2007. The Company made substantial investments to increase its inventory and expand its distribution network throughout the first half of 2008, which significantly offset the Company's cash balance as of June 30, 2008. It is also customary in China's agriculture industry to extend credit terms which allow distributors to pay over a longer period of time than what may be customary in other industries. Consequently, the Company has every reason to believe that its accounts receivable will be paid under the terms extended to its customers. As of June 30, 2008, the Company had total assets of $28.1 million, compared to $23.1 million as of December 31, 2007. Working capital was $17.8 million, total current liabilities were $9.6 million and the Company did not have any short term bank loans or long term liabilities as of June 30, 2008. Stockholders' equity totaled $17.3 million as of June 30, 2008, compared to $12.9 million at the end of 2007.

Recent Events

On April 17, 2008, Yongye Biotechnology International Inc. entered into a share exchange agreement with Fullmax Pacific Limited, British Virgin Islands. All the historical financial statements prior to January 1, 2008 are solely those of the p
'/>"/>

SOURCE Yongye Biotechnology International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Yongye Biotechnology International Announces Conference Call to Discuss Second Quarter 2008 Results
2. Yongye Biotechnology International Retains CCG Investor Relations
3. Yongye Biotechnology International, Inc. Appoints New Independent Auditor
4. Yongye Biotechnology Completes Reverse Merger and Completes $10.0 Million Private Financing
5. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
6. New Book on the Business of Biotechnology
7. InNexus Biotechnology CEO and Chief Scientific Officer to Present at IBCs Annual World Congress Conference in Boston on Aug 6th
8. Champions Biotechnology Reports Fiscal 2008 Full-Year Financial Results
9. Athera Biotechnology Founder Johan Frostegard and His Colleagues Win NACB Distinguished Abstract Award at AACC 2008
10. Pennsylvania Governor Rendell Says State Number 1 in New Biotechnology Study
11. WuXi PharmaTech (NYSE: WX) Wins the 2008 Frost & Sullivan Award for Best in Class Outsourced R&D in Pharmaceuticals and Biotechnology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2015)... , March 29, 2015  Caris ... study data in small cell cervical cancer ... Caris Molecular Intelligence®, the company,s panomic, comprehensive ... gene mutations which may explain sensitivities and ... that identification of certain biomarkers may guide ...
(Date:3/29/2015)... 2015 As a symbol of its ... our pharmaceutical manufacturing clients, Whitehouse Laboratories is excited to ... Berkenstock Race Team for the 2015 race season. Success ... but a strong sense of precision and attention to ... success in the quality control testing laboratory. Sponsorship of ...
(Date:3/27/2015)... March 27, 2015 The consumption of ... of the recession and high prices in 2008. However, ... recovered and keeps on gaining momentum now. , To ... at more than 100,000 thousand tonnes. No considerable growth ... the global capacity rocketed during 2012-2013, registering 11% growth ...
(Date:3/27/2015)... 27, 2015  Neogen Corporation (NASDAQ: NEOG ) ... prearranged trading plan in accordance with Securities and Exchange ... CEO of Neogen Corporation, is a minority owner of ... stock. Herbert does not have control of ... filing is only for a portion of the shares ...
Breaking Biology Technology:Study Using Caris Molecular Intelligence Multiplatform Tumor Profiling Identifies Potential Treatment Strategies for Small Cell Cervical Cancer 2Study Using Caris Molecular Intelligence Multiplatform Tumor Profiling Identifies Potential Treatment Strategies for Small Cell Cervical Cancer 3Whitehouse Laboratories Reaffirms Commitment to Speedy Results – Renews Sponsorship of Berkenstock Racing Team 2World NPK Fertilizers Market Keeps On Gaining Momentum, According to BAC Reports Study Available at MarketPublishers.com 2World NPK Fertilizers Market Keeps On Gaining Momentum, According to BAC Reports Study Available at MarketPublishers.com 3Neogen CEO adopts 10b5-1 Trading Plan 2
... ... Cardiovascular Drug, CALGARY, June ... to developing a portfolio of,therapeutic proteins for metabolic and cardiovascular ... (safflower Apo AI(Milano)) is functional in a widely accepted,animal model. ...
... 5 Anesiva,Inc. (Nasdaq: ANSV ) today ... its NF-kappa B Decoy (NF-kB Decoy) program, which ... Therapeutics,Inc. (TFT). NF-kB Transcription Factor Decoy inhibits NF-kappa ... diseases such as inflammatory,bowel disease (IBD), eczema, rheumatoid ...
... Shuji Nakamura, Director UC Santa Barbara,s Solid-State Lighting and ... 2008 Prince of Asturias Award for Technical and Scientific ... with a medal and a Joan Miro sculpture commissioned ... also share a 50,000 (US$77,000) stipend. , The Technical ...
Cached Biology Technology:SemBioSys Demonstrates Functionality of its Safflower Produced Apo AI(Milano) 2SemBioSys Demonstrates Functionality of its Safflower Produced Apo AI(Milano) 3SemBioSys Demonstrates Functionality of its Safflower Produced Apo AI(Milano) 4Anesiva and Transcription Factor Therapeutics, Inc. Announce Licensing Agreement for Development and Commercialization of NF-kappa B Clinical Program 2Anesiva and Transcription Factor Therapeutics, Inc. Announce Licensing Agreement for Development and Commercialization of NF-kappa B Clinical Program 3
(Date:3/23/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... commerce market, announces its biometric payment technology, the Wocket® smart ... starting March 30 th . The ... New York markets. Gino ... our new ad campaign following the recent initial shipment of ...
(Date:3/20/2015)... Research and Markets ( http://www.researchandmarkets.com/research/vkzvcs/iris_biometrics ) has ... Strategic Business Report" report to their offering. ... US$ Thousands. The report provides separate comprehensive analytics for the ... , Europe , Asia-Pacific ... Latin America . Annual estimates and forecasts ...
(Date:3/17/2015)... , March 17, 2015 Emotient, the ... software, today announced general availability of Emotient ... for the analysis of facial expressions. The system ... media content, products and services. It delivers audience ... and sentiment - as derived from facial evidence ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 2New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 3New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 4
... blockers were first used clinically, scientists can finally get ... beta2-adrenergic receptor. This receptor hails from a family of ... bodily functions, several of our senses, and the action ... the first known structure of a human GPCR, the ...
... study concludes that increasing levels of ozone due to ... vegetation, resulting in serious costs to the world,s economy. ... of Energy Policy, focused on how three environmental changes ... human activity will affect crops, pastures, and forests. ...
... South East Asia with the official launch of SCI ... 27th November 2007. Followed by detailed research ... markets worldwide, with overwhelming support and enthusiasm towards SCIs ... SCI India will offer its membership the opportunity to ...
Cached Biology News:Scientists unveil structure of molecular target of many drugs 2MIT: Human-generated ozone will damage crops 2MIT: Human-generated ozone will damage crops 3SCI marks expansion into Asia with the launch of SCI INDIA 2
... Compound(s) tested through 63 ... assays spanning a broad ... panel includes many non ... several non-selective assays. ...
...
... The Genome Sequencer 20 System revolutionizes ... massively parallel fashion. The Genome Sequencer ... accessories Reagents and consumables for library ... for mapping and de novo assembly ...
... to the maintenance of appropriate levels ... important and diverse as those involved ... stress response, antigen presentation, modulation of ... cell cycle regulation, transcription, and signalling ...
Biology Products: